The request for a second booster shot is based on two real-world data sets suggesting another vaccine dose boosts protection against the Omicron variant while maintaining its safety profile.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
Licensure doesn’t materially affect the status quo — the licensed vaccine’s formula is identical to that authorized for emergency use.
The FDA said it would convene its independent panel of vaccine experts Feb. 15 to consider the data.
The FDA said it would convene its independent panel of vaccine experts Feb. 15 to consider the data.
A flurry of regulatory, testing and logistical issues is complicating the rollout.
A flurry of regulatory, testing and logistical issues is complicating the rollout.
A flurry of regulatory, testing and logistical issues is complicating the rollout.
A flurry of regulatory, testing and logistical issues is complicating the rollout.
Two senators on the panel who caucus with Democrats and six Republicans opposed the nomination.
Two senators on the panel who caucus with Democrats and six Republicans opposed the nomination.
Two senators on the panel who caucus with Democrats and six Republicans opposed the nomination.
Two senators on the panel who caucus with Democrats and six Republicans opposed the nomination.
The advisory panel signed off on the recommendation following presentations by doctors suggesting boosters are likely to increase antibodies in young teens.
The advisory panel signed off on the recommendation following presentations by doctors suggesting boosters are likely to increase antibodies in young teens.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
The advisory panel signed off on the recommendation following presentations by doctors suggesting boosters are likely to increase antibodies in young teens.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
The advisory panel signed off on the recommendation following presentations by doctors suggesting boosters are likely to increase antibodies in young teens.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
The advisory panel signed off on the recommendation following presentations by doctors suggesting boosters are likely to increase antibodies in young teens.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
The advisory panel signed off on the recommendation following presentations by doctors suggesting boosters are likely to increase antibodies in young teens.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
The agency will also allow some immunocompromised children as young as age 5 to get an additional dose.
CDC Director Rochelle Walensky’s decision came hours after the agency’s vaccine advisory committee voted unanimously to update the recommendation.
CDC Director Rochelle Walensky’s decision came hours after the agency’s vaccine advisory committee voted unanimously to update the recommendation.